Q1 2025 Management View CEO Mark Crossley stated that Q1 financial results were in line with expectations, despite a 6% ...

SUBLOCADE use during pregnancy showed no increased risk of birth defects, miscarriage, or maternal complications compared to general population rates RICHMOND, Va., May 1, 2025 /PRNewswire ...

Indivior PLC’s recovery hinges on Sublocade’s momentum and market trends, though risks persist in litigation and earnings.

The FDA agreed and the orphan status was carried on to two new formulations of the drug, based around buprenorphine, including the latest long-lasting monthly dose version Sublocade. This has ...

That was driven by its buprenorphine-based opioid withdrawal product Sublocade, which contributed $756 million of that total. This year, however, competition in the US is expected to peg back ...

In addition, I am experienced in the pharmacological treatment of substance abuse including the use of Suboxone, Sublocade, Vivitrol, and Medical Marijuana. I also have experience with treatment ...

People who use substances like opioids deserve dignity and respect, just like anyone else. A compassionate approach to care that centers on the patient’s individual goals is embraced at ...

Indivior PLC (Nasdaq/LSE: INDV) today announced the publication of a study "Monthly Buprenorphine Depot Injection (SUBLOCADE) for Opioid Use Disorder During Pregnancy" in the American Journal on ...